157 related articles for article (PubMed ID: 36251064)
1. Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review.
Nugroho PP; Ghozali SAS; Buchanan DD; Pisano MI; Reece JC
J Cancer Res Clin Oncol; 2023 Jan; 149(1):25-46. PubMed ID: 36251064
[TBL] [Abstract][Full Text] [Related]
2. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
[TBL] [Abstract][Full Text] [Related]
3. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of Lynch-like syndrome.
Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T
Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190
[TBL] [Abstract][Full Text] [Related]
5. Implication of DNA repair genes in Lynch-like syndrome.
Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
[TBL] [Abstract][Full Text] [Related]
6. Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.
Picó MD; Sánchez-Heras AB; Castillejo A; Giner-Calabuig M; Alustiza M; Sánchez A; Moreira L; Pellise M; Castells A; Llort G; Yagüe C; Ramon Y Cajal T; Gisbert-Beamud A; Cubiella J; Rivas L; Herraiz M; Garau C; Salces I; Carrillo-Palau M; Bujanda L; López-Fernández A; Alvarez-Urturi C; López MJ; Alenda C; Zapater P; Lacueva FJ; Balaguer F; Soto JL; Murcia Ó; Jover R
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784934
[TBL] [Abstract][Full Text] [Related]
7. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
[TBL] [Abstract][Full Text] [Related]
8. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study.
Porkka N; Lahtinen L; Ahtiainen M; Böhm JP; Kuopio T; Eldfors S; Mecklin JP; Seppälä TT; Peltomäki P
Int J Cancer; 2019 Jul; 145(1):87-98. PubMed ID: 30575961
[TBL] [Abstract][Full Text] [Related]
10. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.
Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C;
Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Pathological Characterization of Lynch-Like Syndrome.
Picó MD; Castillejo A; Murcia Ó; Giner-Calabuig M; Alustiza M; Sánchez A; Moreira L; Pellise M; Castells A; Carrillo-Palau M; Ramon Y Cajal T; Gisbert-Beamud A; Llort G; Yagüe C; López-Fernández A; Alvarez-Urturi C; Cubiella J; Rivas L; Rodríguez-Alcalde D; Herraiz M; Garau C; Dolz C; Bujanda L; Cid L; Povés C; Garzon M; Salces I; Ponce M; Hernández-Villalba L; Alenda C; Balaguer F; Soto JL; Jover R
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):368-374.e1. PubMed ID: 31220642
[TBL] [Abstract][Full Text] [Related]
12. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.
Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes.
Xu Y; Huang Z; Li C; Zhu C; Zhang Y; Guo T; Liu F; Xu Y
Front Genet; 2020; 11():991. PubMed ID: 32973888
[TBL] [Abstract][Full Text] [Related]
14. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
Carwana H; Hoodfar E; Bergoffen J; Li D
Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
[TBL] [Abstract][Full Text] [Related]
16. Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis.
Abu-Ghazaleh N; Kaushik V; Gorelik A; Jenkins M; Macrae F
Genet Med; 2022 May; 24(5):971-985. PubMed ID: 35177335
[TBL] [Abstract][Full Text] [Related]
17. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
[TBL] [Abstract][Full Text] [Related]
19. Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach.
Bu R; Siraj AK; Parvathareddy SK; Iqbal K; Azam S; Qadri Z; Al-Rasheed M; Haqawi W; Diaz M; Alobaisi K; Annaiyappanaidu P; Siraj N; AlHusaini H; Alomar O; Al-Badawi IA; Al-Dayel F; Al-Kuraya KS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293153
[TBL] [Abstract][Full Text] [Related]
20. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
